Insight into mithramycin disruption of ETS transcription leads to improved understanding of more selective analogs.
Journal
Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697
Informations de publication
Date de publication:
06 05 2021
06 05 2021
Historique:
entrez:
7
5
2021
pubmed:
8
5
2021
medline:
1
6
2021
Statut:
ppublish
Résumé
Fusion products with the ETS family of transcription factors play critical roles in the etiology of several cancers. In this issue of Structure, Hou et al. (2020) provide insight into allosteric mechanisms by which mithramycin and its analogs perturb protein-DNA interactions in higher-order complexes at a DNA enhancer site.
Identifiants
pubmed: 33961789
pii: S0969-2126(21)00083-6
doi: 10.1016/j.str.2021.03.010
pii:
doi:
Substances chimiques
Transcription Factors
0
DNA
9007-49-2
Plicamycin
NIJ123W41V
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
401-403Subventions
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.